• Repackaging the Rules . . . FDA's New Regulations for Prescription Drug Labeling and the Impact of Abramowitz
  • June 22, 2006 | Author: Lynn Shapiro Snyder
  • Law Firm: Epstein Becker & Green, P.C. - Washington Office
  • On January 18, 2006, FDA announced substantial changes to the prescription drug labeling process, detailing requirements for all package inserts for new products and products approved in the past five years. These revisions, the first in nearly twenty-seven years, were implemented to aid physicians and patients alike in locating key prescription information in an expedited manner.